E. Kyrmanidou, “A Real-Life 208 Week Single-Centred, Register-Based Retrospective Study Assessing Secukinumab Survival and Long-Term Efficacy and Safety Among Greek Patients With Moderate to Severe Plaque Psoriasis, Including Difficult-to-Treat Manifestations Such as Genitals and Scalp”, Dermatol Pract Concept, vol. 14, no. 2, p. e2024119, Apr. 2024, doi: 10.5826/dpc.1402a119.